Has the news around Vertex Pharmaceuticals effected PXS share price? from what I understand this treatment only expands their market by 750 patients (300k each). PXS could learn from the approach, get the product in the market with a smaller "tried and tested" subgroup, then grow.
As a bigger question, can PXS really survive (financially) until the completion of the trial 3, and FDA result?
It was always a gamble.
- Forums
- ASX - By Stock
- SNT
- Vertex Pharmaceuticals & cash
Vertex Pharmaceuticals & cash
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.49M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 104547 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 1104152 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 104547 | 0.018 |
2 | 322319 | 0.017 |
5 | 1924922 | 0.016 |
12 | 4795390 | 0.015 |
13 | 3541789 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 1104152 | 4 |
0.019 | 257571 | 2 |
0.020 | 609927 | 10 |
0.021 | 455000 | 1 |
0.022 | 760259 | 3 |
Last trade - 08.41am 15/05/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
Day chart unavailable